During the past decade, Centralny Szpital Kliniczny MSW conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 40 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 29 clinical trials were completed. i.e. 103.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centralny Szpital Kliniczny MSW" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Janssen Research & Development, LLC" with 10 trials sponsored, "Gilead Sciences" with 9 trials sponsored, "Shire" with 7 trials sponsored and "Pfizer" with 7 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centralny Szpital Kliniczny MSW" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Centralny Szpital Kliniczny MSW" are "Crohn's Disease" (15 trials), "Ulcerative Colitis" (13 trials), "Colitis, Ulcerative" (6 trials), "Atopic Dermatitis" (5 trials) and "Crohn Disease" (4 trials). Many other conditions were trialed in "Centralny Szpital Kliniczny MSW" in a lesser frequency.

Most popular intervention types in "Centralny Szpital Kliniczny MSW" are "Drug" (71 trials), "Biological" (13 trials), "Other" (9 trials), "Device" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Filgotinib" (4 trials), "Guselkumab Dose 1" (4 trials), "Guselkumab Dose 2" (4 trials) and "Ontamalimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Centralny Szpital Kliniczny MSW" are 82 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centralny Szpital Kliniczny MSW". undefined are not yet recruiting, 16 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 45 completed trials in Centralny Szpital Kliniczny MSW, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Centralny Szpital Kliniczny MSW, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".

Centralny Szpital Kliniczny MSW has several departments that took part in Clinical trials: "Centralny Szpital Kliniczny MSWiA, Klinika Chorob Wewnetrznych i Gastroenterologii" - 4 trials, "Centralny Szpital Kliniczny MSWiA w Warszawie, Klinika Poloznictwa, Chorob Kobiecych i Ginekologii Onkologicznej" - 3 trials, "Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych" - 2 trials, "Centralny Szpital Kliniczny MSW Klinika Dermatologii" - 2 trials, "Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administracji w Warszawie, Klinika Chorob Wewnetrznych, Nefrologii i Transplantologii" - 2 trials, "Centralny Szpital Kliniczny MSWiA; Oddzial Chorob Wewnetrznych i Hepatologii" - 2 trials